CVE-2026-95165: Bacularis stored cross-site scripting in Organization name

CVE-2026-95165 · Severity: info · Published 2026-10-05

Bacularis is a web-based backup and recovery management system. A stored cross-site scripting (XSS) vulnerability in the Organization name field allows attackers to inject malicious scripts that execute when other users view the affected organization. This could lead to session hijacking, credential theft, or unauthorized actions performed on behalf of authenticated users.

Technologies: Bacularis. Vendors: Bacularis.

Quick answers

Is CVE-2026-95165 exploited in the wild?
No. Junglewise Threat Intelligence has no report of CVE-2026-95165 being exploited in the wild.
How severe is CVE-2026-95165?
Informational severity, published 5 October 2026.
Which products and versions are affected?
Bacularis 5.4.0 - 6.5.1.
Is there a fix for CVE-2026-95165?
No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
How is CVE-2026-95165 attacked?
It is attacked over the network, in a web application.
Am I affected by CVE-2026-95165?
Check whether you run Bacularis at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.

Technical details

The vulnerability is a stored XSS flaw in the Organization name field of Bacularis versions 5.4.0 through 6.5.1. Input validation is insufficient, allowing an attacker with appropriate access to create or modify an organization and inject JavaScript code that persists in the application. When other users access the organization, the malicious script executes in their browser context.

Affected products

  • Bacularis Bacularis 5.4.0 - 6.5.1

Timeline

  • 2026-10-05: disclosed

References

This page as Markdown. Free to reuse under CC BY 4.0 with a link back.